Evonik’s supervisory board unanimously elected Dr. Werner Mueller to the position of Honorary Chairman at its meeting on March 5. Thereby, the supervisory board followed the proposal of Evonik’s executive board and with the vote is expressly acknowledging Mueller’s outstanding achievements with regard to the company.
“Werner Mueller founded, led and helped make Evonik into the company it is today,” said Christian Kullmann, Chairman of the Executive Board. “Without him, there would be no Evonik.”
Last week Mueller announced that he would step down from his position as Chairman of the Supervisory Board at the end of the annual shareholders’ meeting on May 23.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.